Publication|Videos|July 18, 2024
PurpleLab Accelerates Clinical Trial Lifecycle with Real-World-Data
Author(s)PurpleLab
Jason Gagner (Vice President of Product for Life Science, PurpleLab) talks about clinical trial variables and how PurpleLab is working to maintain patient retention and accelerate site feasibility.
Approximately 80% of clinical trials will face delays at some point in the trial process. Jason Gagner talked with ACT about how PurpleLab uses real-world data to better inform trials and improve their success rates.
Learn More About:
- Utilizing real-world data (RWD) to assist clinical trials achieve key milestones
- Employing a criteria specific geographic analysis of patient populations to expedite site feasibility assessments
- Understanding the impact of diversity, equity, and inclusion (DEI) in clinical trials on meeting trial objectives and timelines
- Integrating social determinants of health (SDOH) data to minimize patient dropout rates
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies
3
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
4
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
